Table 4.

Adverse events distribution in patients aged <65 and ≥65 years

	<65 years (n = 1915)			≥65 years (n = 897)
	n	%	E	n	%	E
Adverse events (AEs)	321	16.8	578	163	33.1	281
Serious adverse events (SAEs)	99	5.2	137	69	7.7	93
Insulin detemir-related AEs (probably/possibly related)	86	4.5	140	32	3.6	58

E number of events